CF
NEO icon

Corebridge Financial’s NeoGenomics NEO Stock Holding History

Corebridge Financial’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-66,612
Closed -$632K – 1777
2025
Q1 		$632K Sell
66,612
-1,306
-2% -$16.3K ﹤0.01% 1471
2024
Q4 		$1.12M Sell
67,918
-5,296
-7% -$82.2K 0.01% 1283
2024
Q3 		$1.08M Sell
73,214
-757
-1% -$11.8K 0.01% 1325
2024
Q2 		$1.03M Buy
+73,971
New +$1.05M 0.01% 1328

Other funds holding NEO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Corebridge Financial's NEO Position: Q2 2025 in Review

Corebridge Financial sold out of NeoGenomics (NEO) in Q2 2025, closing a stake of 66,612 shares — an estimated $632K sold.

Corebridge Financial first reported a position in NEO in Q2 2024 and held it in 4 quarters. The position peaked at $1.12M in Q4 2024. 274 funds tracked by Wall St. Rank hold NEO as of Q2 2025.

  • Corebridge Financial reported no remaining NeoGenomics position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 66,612 NeoGenomics shares in Q2 2025, an estimated $632K.
  • Corebridge Financial first reported a position in NeoGenomics in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's NeoGenomics position peaked at $1.12M in Q4 2024.
  • 274 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.